INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 240 filers reported holding INSMED INC in Q3 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $972,176 | +24.7% | 38,502 | -15.8% | 0.04% | +9.1% |
Q1 2023 | $779,373 | +18.1% | 45,711 | +49.1% | 0.03% | -19.5% |
Q3 2022 | $660,000 | +45.1% | 30,651 | +58.2% | 0.04% | +127.8% |
Q1 2022 | $455,000 | -25.2% | 19,379 | +8.6% | 0.02% | -40.0% |
Q1 2021 | $608,000 | -19.1% | 17,850 | -21.0% | 0.03% | -9.1% |
Q4 2020 | $752,000 | +265.0% | 22,589 | +253.0% | 0.03% | +230.0% |
Q3 2020 | $206,000 | -74.2% | 6,400 | -80.9% | 0.01% | -71.4% |
Q4 2019 | $800,000 | -2.0% | 33,491 | -27.6% | 0.04% | -14.6% |
Q3 2019 | $816,000 | – | 46,238 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |